MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
7 hedge funds and large institutions have $505K invested in MedAvail Holdings, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
266% more capital invested
Capital invested by funds: $138K → $505K (+$367K)
40% more funds holding
Funds holding: 5 → 7 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$125K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$49.7K |
| 3 |
BlackRock
New York
|
+$1.84K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.84K |
| 5 |
FPF
FNY Partners Fund
New York
|
+$1.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.84K |
MDVL Hedge Fund Activity: Q1 2017 in Review
7 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q1 2017, worth a combined $505K — up 266% from $138K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MDVL positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $125K. The largest seller was UBS Group, exiting entirely with an estimated $1.84K sold.
- 7 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q1 2017, up from 5 in Q4 2016.
- Funds reported $505K of MedAvail Holdings, Inc. Common Stock stock for Q1 2017, up 266% quarter-over-quarter.
- 4 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q1 2017 and 1 closed out, a net change of +3 holders.
- The largest MedAvail Holdings, Inc. Common Stock buyer in Q1 2017 was Morgan Stanley, an estimated $125K added.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q1 2017 was UBS Group, an estimated $1.84K sold.
Based on aggregated 13F filings for Q1 2017.